ABO blood groups, COVID-19 infection and mortality
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 89, 102571
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (S10OD026880, S10OD018522)
This publication has 16 references indexed in Scilit:
- Genomewide Association Study of Severe Covid-19 with Respiratory FailureNew England Journal of Medicine, 2020
- Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) SusceptibilityClinical Infectious Diseases, 2020
- Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community CohortThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2020
- ABO blood group predisposes to COVID-19 severity and cardiovascular diseasesEuropean Journal of Preventive Cardiology, 2020
- Genetically Determined ABO Blood Group and its Associations With Health and DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2020
- Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysisBMC Medical Genetics, 2020
- Post-lingual non-syndromic hearing loss phenotype: a polygenic case with 2 biallelic mutations in MYO15A and MITFBMC Medical Genetics, 2020
- Pancreatic Cancer Risk and ABO Blood Group Alleles: Results from the Pancreatic Cancer Cohort ConsortiumCancer Research, 2010
- Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 WomenPLOS Genetics, 2008
- A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)PLOS Genetics, 2008